Reactive hyperaemia index as a marker of endothelial dysfunction in children with Crohn's disease is significantly lower than healthy controls

Patients with inflammatory bowel disease (IBD) are prone to cardiovascular disorders, although there is little research to support this assertion, and other data are controversial in children. We aimed to determine the extent of premature atherosclerosis in Crohn's disease (CD) by measuring reactive hyperaemia index (RHI) as a functional marker of endothelial dysfunction (ED).

[1]  G. Di Nardo,et al.  Premature subclinical atherosclerosis in pediatric inflammatory bowel disease. , 2012, The Journal of pediatrics.

[2]  G. Murdaca,et al.  Endothelial dysfunction in rheumatic autoimmune diseases. , 2012, Atherosclerosis.

[3]  M. Satoh.  Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease , 2012, Clinical and Experimental Nephrology.

[4]  L. Vanhees,et al.  Reproducibility of different methods to measure the endothelial function , 2012, Vascular medicine.

[5]  N. Çullu,et al.  Evaluation of Early Atherosclerosis in Patients with Inflammatory Bowel Disease , 2012, Digestive Diseases and Sciences.

[6]  M. Moerland,et al.  Evaluation of the EndoPAT as a Tool to Assess Endothelial Function , 2012, International journal of vascular medicine.

[7]  David C Wilson,et al.  Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.

[8]  T. Şahin,et al.  Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. , 2011, Endocrine journal.

[9]  S. Carerj,et al.  Early Identification of Vascular Damage in Patients With Systemic Sclerosis , 2011, Angiology.

[10]  J Michael Mathis,et al.  Role of the endothelium in inflammatory bowel diseases. , 2011, World journal of gastroenterology.

[11]  M. Behr.  The path to Crohn's disease: is mucosal pathology a secondary event? , 2010, Inflammatory bowel diseases.

[12]  S. Yusuf,et al.  Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth. , 2010, Atherosclerosis.

[13]  D. Owczarek,et al.  Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and 8‐iso‐prostaglandin F2&agr; (8‐iso‐PGF2&agr;) level in patients with inflammatory bowel diseases , 2010, Inflammatory bowel diseases.

[14]  E. Scapa,et al.  Intima-Media Thickness of the Common Carotid Artery Is Not Significantly Higher in Crohn’s Disease Patients Compared to Healthy Population , 2010, Digestive Diseases and Sciences.

[15]  P. Währborg,et al.  Anger, depression and anxiety associated with endothelial function in childhood and adolescence , 2009, Archives of Disease in Childhood.

[16]  M. Krueger.  Of Youth , 2009, The Five.

[17]  Shun-le Chen,et al.  Evaluation of Risk Factors That Contribute to High Prevalence of Premature Atherosclerosis in Chinese Premenopausal Systemic Lupus Erythematosus Patients , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[18]  O. Mayer,et al.  Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1. , 2009, Physiological Research.

[19]  K. Chadee,et al.  Biologic Therapies Against Inflammatory Bowel Disease: A Dysregulated Immune System and the Cross Talk with Gastrointestinal Mucosa Hold the Key , 2008 .

[20]  R. Kharbanda,et al.  Measurement of endothelial function and its clinical utility for cardiovascular risk , 2008, Vascular health and risk management.

[21]  Ramachandran S Vasan,et al.  Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study , 2008, Circulation.

[22]  H. Klein,et al.  Influence of the duration of type 2 diabetes on early functional and morphological markers of atherosclerosis compared to the impact of coexisting classic cardiovascular risk factors. , 2008, Experimental and clinical endocrinology & diabetes.

[23]  A. Armuzzi,et al.  Tumor Necrosis Factor‐α Antagonism Improves Endothelial Dysfunction in Patients With Crohn's Disease , 2008 .

[24]  K. Chadee,et al.  Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. , 2008, Current molecular pharmacology.

[25]  A. Armuzzi,et al.  Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. , 2008, Clinical pharmacology and therapeutics.

[26]  D. Rość,et al.  [Value of E-selectin and L-selectin determination in children and youth with inflammatory bowel disease]. , 2007, Medycyna wieku rozwojowego.

[27]  Z. Halpern,et al.  Inflammatory Bowel Disease Is Not Associated With Increased Intimal Media Thickening , 2007, The American Journal of Gastroenterology.

[28]  T. Hibi,et al.  Colonic blood flow responses in experimental colitis: time course and underlying mechanisms. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[29]  B. Koletzko,et al.  ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition - Annex: List of Products , 2005, Journal of pediatric gastroenterology and nutrition.

[30]  J. Hugot,et al.  Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. , 2005, Journal of pediatric gastroenterology and nutrition.

[31]  Amir Lerman,et al.  Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. , 2004, Journal of the American College of Cardiology.

[32]  D. Granger,et al.  Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. , 2001, Microvascular research.

[33]  S. Nakamura,et al.  In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[34]  J T Boyle,et al.  Development and validation of a pediatric Crohn's disease activity index. , 1991, Journal of pediatric gastroenterology and nutrition.